NDC 61715-033-32 - Preferred Plus Urinary Pain Relief
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 61715-033
- Requested NDC
- 61715-033-32
- Package NDCs from labels
- 61715-033-32, 61715-033-01
- Manufacturer
- Kinray | Reese Pharmaceutical Co
- Effective date
- 2013-03-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Preferred Plus Urinary Pain Relief - Kinray | Reese Pharmaceutical Co | Kinray | Reese Pharmaceutical Co | 2013-03-01 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61715-033-01 | 2020-02-13 | C162847 | 48780-1 | 9d75b9d1-0b73-f424-e053-dadaa90a57ce | DRUG FACTS |
| 61715-033-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0b73-f424-e053-dadaa90a57ce | DRUG FACTS |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Harris Teeter Eye Drops Artificial Tears | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Harris Teeter, LLC. | f82957d9-c4ad-a914-e053-6294a90aac50 | 2025-12-30 | Warnings | 3NXW29V3WO |
| CVS Gentle Tears | DEXTRAN 70, HYPROMELLOSE | CVS Pharmacy, Inc. | 9b1ea0eb-c34f-6603-e053-2995a90a6a95 | 2025-12-30 | Warnings | 3NXW29V3WO |
| Maximum Strength Urinary Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | TARGET CORPORATION | e6e27e7f-d04c-5a49-e053-2a95a90a776a | 2025-12-30 | Warnings | 0EWG668W17 |
| Vexia Maximum Strength Urinary Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | Reese Pharmaceutical Co | 5fbc47d2-cecd-4187-9bcc-51b1d0b7695d | 2025-12-29 | Warnings | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | Northwind Health Company, LLC | f29f2ed6-6fd1-fd65-e053-2a95a90aedc4 | 2025-12-26 | Adverse reactions | 0EWG668W17 |
| Artificial Tears | GLYCERIN | Geri-Care Pharmaceuticals, Corp | 7cc437e3-bad9-59be-e053-2991aa0a1da3 | 2025-12-19 | Warnings | 3NXW29V3WO |
| Artificial Tears | GLYCERIN | NuCare Pharmaceuticals,Inc. | 97a3d8e2-b2c0-3f5d-e053-2a95a90ac49d | 2025-12-15 | Warnings | 3NXW29V3WO |
| PHENAZOPYRIDINE HYDROCHLORIDE | PHENAZOPYRIDINE HYDROCHLORIDE | Chartwell RX, LLC | 9ed3cf8c-e1c1-4290-b094-25ac6f7a9a56 | 2025-12-11 | Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | A-S Medication Solutions | d514fd31-feeb-4371-9b28-eec9834a7003 | 2025-12-10 | Warnings, Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | A-S Medication Solutions | cd78a132-037c-412a-9c56-e38367e05c92 | 2025-12-10 | Warnings, Adverse reactions | 0EWG668W17 |
| Quality Choice Urinary Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | Chain Drug Marketing Association | 45e0cc2f-4a25-40ef-86ed-d1212815d751 | 2025-12-02 | Warnings | 0EWG668W17 |
| Quality Choice Maximum Strength Urinary Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | Chain Drug Marketing Association | 3cee4fea-f1ef-4020-9b55-02b794b12820 | 2025-12-02 | Warnings | 0EWG668W17 |
| AZO Urinary Pain Relief Maximum Strength | PHENAZOPYRIDINE HYDROCHLORIDE | i-Health, Inc. | b4874fe2-d98b-4b5c-baad-d75070947842 | 2025-11-17 | Warnings | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | VERITYRX, LLC | 427b6ffb-3ff1-932f-e063-6394a90ae8b9 | 2025-10-31 | Adverse reactions | 0EWG668W17 |
| Uqora Maximum UTI Pain Relief | PHENAZOPYRIDINE HYDROCHLORIDE | Bonafide Health, LLC dba Uqora | 426317e7-a925-116a-e063-6294a90a52dc | 2025-10-27 | Warnings | 0EWG668W17 |
| Uristat Ultra | PHENAZOPYRIDINE HYDROCHLORIDE | Medtech Products Inc. | c705185f-4908-451e-993b-b0b8a73f0392 | 2025-10-23 | Warnings | 0EWG668W17 |
| Monistat Maintain | PHENAZOPYRIDINE HYDROCHLORIDE | Insight Pharmaceuticals LLC | d1e563fc-5a91-4867-8177-93102bd24fe4 | 2025-10-23 | Warnings | 0EWG668W17 |
| Sugar Cravings | CINNAMIC ACID, PHLORIDZINUM, ARGENTUM NITRICUM, ADENOSINUM TRIPHOSPHORICUM DINATRUM, BEET SUGAR, DEXTROSE, D-RIBOSE, FRUCTOSE, LYCOPODIUM CLAVATUM, MAPLE SUGAR, SACCHARUM LACTIS, SACCHARUM OFFICINALE, SARCOLACTICUM ACIDUM, MALVIN, ADRENOCORTICOTROPHIN, DYSENTERY BACILLUS, MORGAN GAERTNER | Dr. Donna Restivo DC | 401873ba-ae1b-4506-a2e8-c6c0e5ff27f5 | 2025-10-21 | Warnings | J2B2A4N98G |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | Bryant Ranch Prepack | 6ac0f3ce-0cc2-403c-946d-13b285ae98aa | 2025-09-19 | Adverse reactions | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | A-S Medication Solutions | d8155f91-d650-4021-91ee-f3b6c1055a36 | 2025-09-05 | Adverse reactions | 0EWG668W17 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.